Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind trial of Shanggan Qingre Oral Liquid for common cold (wind-heat pattern)
CTR20251167Phase 2Active
- Sponsor
- Xi'an Shangyikang Pharmaceutical Research Institute
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shanggan Qingre Oral Liquid in nasopharyngitis, sponsored by Xi'an Shangyikang Pharmaceutical Research Institute. Started Apr 2025; status: active.
02
Drugs
Shanggan Qingre Oral Liquid
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20251167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251167.